Frontiers | Phosphodiesterases and cAMP Pathway in Pituitary Diseases
CV Pharmacology | Phosphodiesterase Inhibitors
Inhibition of phosphodiesterase type 1 (PDE1) lead to the increase of... | Download Scientific Diagram
CV Pharmacology | Phosphodiesterase Inhibitors
Channeling of cAMP in PDE-PKA Complexes Promotes Signal Adaptation - ScienceDirect
IJMS | Free Full-Text | Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
Selection of a Promiscuous Minimalist cAMP Phosphodiesterase from a Library of De Novo Designed Proteins | bioRxiv
Phosphodiesterases as therapeutic targets for respiratory diseases - ScienceDirect
FAM-cAMP PDE IV substrate *Green Fluorescence* | AAT Bioquest
Role of phosphodiesterase enzymes (PDEs) in the metabolism of cyclic... | Download Scientific Diagram
Frontiers | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
Figure 1 from Phosphodiesterases Catalyze Hydrolysis of cAMP-bound to Regulatory Subunit of Protein Kinase A and Mediate Signal Termination* | Semantic Scholar
SciELO - Brasil - Nonsteroidal anti-inflammatory drugs as potential ecto-nucleotide phosphodiesterase inhibitors Nonsteroidal anti-inflammatory drugs as potential ecto-nucleotide phosphodiesterase inhibitors
Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts | Acta Pharmacologica Sinica
Anti-platelet therapy: phosphodiesterase inhibitors. - Abstract - Europe PMC
Phosphodiesterase 4 inhibitor activates AMPK-SIRT6 pathway to prevent aging-related adipose deposition induced by metabolic disorder | Aging
Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure | Cardiovascular Drugs and Therapy
Frontiers | The regulatory role of PDE4B in the progression of inflammatory function study
Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in Leydig cell function with phosphoproteomics - ScienceDirect
Phosphodiesterase 3 - Wikipedia
Regulation of Phosphodiesterase 3 in the Pulmonary Arteries During the Perinatal Period in Sheep | Pediatric Research
Inhibit a Phosphodiesterase to Treat Heart Failure? | Circulation
Phosphodiesterase Screening and Profiling Services
CV Pharmacology | Phosphodiesterase Inhibitors
Phosphodiesterases catalyze hydrolysis of cAMP-bound to regulatory subunit of protein kinase A and mediate signal termination. - Abstract - Europe PMC
Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders | Molecular Psychiatry
